Acquisition Announced
Galmed Pharmaceuticals acquisition of Colospan
US$4.5m consideration
Announced 8 Jun 2026
Advisers
Colospan
Target
- Legal adviser
- Matry Meiri Wacht & Co.
Galmed Pharmaceuticals
Acquirer
- Financial adviser
- Legal adviser
- Target
- Colospan
- Acquirer
- Galmed Pharmaceuticals
- Target based in
- Israel
- Buyer based in
- Israel
- Sector
- Medtech
Similar deals
- Alcidion Group acquisition of Kyra flow products May 2026 · US$2.1m · Medtech
- Isto Biologics acquisition of NovaBone Products Aug 2026 · US$60m · Medtech
- Zimmer Biomet Holdings acquisition of Pacira's iovera° business Jun 2026 · US$70m · Medtech
- Lazard Elaia Capital stake in DentalMonitoring Feb 2026 · US$100m · Medtech
- Kimball Electronics acquisition of Helvoet Polymer Technologies Jul 2026 · US$104m · Contract Manufacturing
